Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EEF1A1 antisense RNA 1 (EEF1A1-AS1) is a naturally occurring long non-coding RNA transcribed from the DNA strand antisense to the EEF1A1 protein-coding gene. NATs such as EEF1A1-AS1 can regulate the expression of their corresponding sense gene (often modulating mRNA stability, splicing, or translation), and may play broader regulatory roles in cell biology. While some NATs have been implicated in disease processes such as cancer, there is no direct evidence provided here on disease involvement for EEF1A1-AS1 specifically.
For NATs in general, mechanisms include binding to complementary sense mRNA to modulate its stability, splicing, or translation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on EEF1A1 antisense RNA 1 (EEF1A1-AS1).